<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ftcsx — News on 6ix</title>
    <link>https://6ix.com/company/ftcsx</link>
    <description>Latest news and press releases for Ftcsx on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/ftcsx" rel="self" type="application/rss+xml" />
    <item>
      <title>First Merchants Corporation Announces First Quarter 2026 Results</title>
      <link>https://6ix.com/company/ftcsx/news/first-merchants-corporation-announces-first-quarter-2026-results-1</link>
      <guid isPermaLink="true">https://6ix.com/company/ftcsx/news/first-merchants-corporation-announces-first-quarter-2026-results-1</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>MUNCIE, Ind., April 22, 2026 (GLOBE NEWSWIRE) -- First Merchants Corporation (NASDAQ - FRME) (the &quot;Corporation&quot;) First Quarter 2026 Highlights: Net income</description>
    </item>
    <item>
      <title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
      <link>https://6ix.com/company/ftcsx/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-27</link>
      <guid isPermaLink="true">https://6ix.com/company/ftcsx/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-27</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (&quot;Company&quot;), a global device, cell, and gene therapy-enabling</description>
    </item>
    <item>
      <title>Goosehead Insurance, Inc. Appoints John Martin as Chief Financial Officer and Promotes Mark Jones, Jr. to President and Chief Operating Officer</title>
      <link>https://6ix.com/company/ftcsx/news/goosehead-insurance-inc-appoints-john-martin-as-chief-financial-officer-and-promotes-mark-jones-jr-to-president-and-chief-operating-officer-3</link>
      <guid isPermaLink="true">https://6ix.com/company/ftcsx/news/goosehead-insurance-inc-appoints-john-martin-as-chief-financial-officer-and-promotes-mark-jones-jr-to-president-and-chief-operating-officer-3</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>WESTLAKE, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD) today announced the appointment of</description>
    </item>
    <item>
      <title>First Northern Community Bancorp Announces Approval for Listing on The Nasdaq Capital Market</title>
      <link>https://6ix.com/company/ftcsx/news/first-northern-community-bancorp-announces-approval-for-listing-on-the-nasdaq-capital-market-6</link>
      <guid isPermaLink="true">https://6ix.com/company/ftcsx/news/first-northern-community-bancorp-announces-approval-for-listing-on-the-nasdaq-capital-market-6</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>DIXON, Calif.--(BUSINESS WIRE)-- First Northern Community Bancorp (the “Company”), parent company of First Northern Bank, today announced that it has</description>
    </item>
  </channel>
</rss>